DAR-0100A

Unknown Manufacturer

DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder).

Generate AI report

Overview

DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder).

Technical identifiers

Chemical Formula: C₁₇H₁₇NO₂
CAS Number: 174691-84-0
UNII ID: Q3PJ4B4D0X

Drugs